Drugs / Flotufolastat F-18 Injection
Flotufolastat F-18 Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07115277 | Mar 2025 → Dec 2026 expected | prostate cancer | Sinotau Pharmaceutical Group | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flotufolastat F-18 Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07115277 ↗ |
| Modality | Diagnostic / imaging agent | “a PET radiopharmaceutical selective for PSMA” NCT07115277 ↗ |
| Route | Intravenous | “IV as a bolus injection” NCT07115277 ↗ |